![](/img/cover-not-exists.png)
P-058 * Moderate neutropenia is a predictor of better prognosis in metastatic gastric cancer patients treated with the combination regimen of epirubicin, oxaliplatin and 5-fluorouracil
Liu, R., Zhu, X.Volume:
26
Language:
english
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdv233.58
Date:
June, 2015
File:
PDF, 63 KB
english, 2015